Protagonist Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Protagonist Therapeutics Inc
TickerPTGX
CIK #0001377121
CUSIP74366E102
SectorLife Sciences - Pharmaceutical Preparations
Address521 Cottonwood Drive, Suite 100, Malpitas, CA 95035-7404
Source [EDGAR]
CIK Filing 2011 - 2025
[0001377121] 10-K
[0001377121] 10-Q
[0001377121] 3
[0001377121] 4
[0001377121] 5
[0001377121] 8-K
[0001377121] D
[0001377121] SC 13D
[0001377121] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Protagonist Therapeutics Inc [2025-08-11] 0.0
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2025-06-16] 0.0
State Street Corp Protagonist Therapeutics Inc [2025-05-13] 0.0
Deep Track Capital LP Protagonist Therapeutics Inc [2025-04-10] 0.0
State Street Corp Protagonist Therapeutics Inc [2024-10-16] 5.4
Point72 Asset Management LP Protagonist Therapeutics Inc [2023-12-18] 5.5
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2023-04-13] 5.44
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2023-03-20] 5.1
Vanguard Group Inc Protagonist Therapeutics Inc [2023-02-09] 6.3
Citadel Advisors LLC Protagonist Therapeutics Inc [2023-01-03] 3.6
State Street Corp Protagonist Therapeutics Inc [2022-02-10] 5.39
Point72 Asset Management LP Protagonist Therapeutics Inc [2021-09-21] 0.1
Consonance Capital Management LP Protagonist Therapeutics Inc [2021-02-17] 5.75
Consonance Capital Management LP Protagonist Therapeutics Inc [2021-02-16] 5.75
BlackRock Inc Protagonist Therapeutics Inc [2021-02-02] 6.2
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2020-05-22] 6.39
BlackRock Inc Protagonist Therapeutics Inc [2020-02-07] 5.7
RTW Investments LP Protagonist Therapeutics Inc [2019-12-16] 8.04
Integrated Core Strategies US LLC Protagonist Therapeutics Inc [2019-07-01] 3.5
Venrock Healthcare Capital Partners II LP Protagonist Therapeutics Inc [2019-06-17] 6.4
Perceptive Advisors LLC Protagonist Therapeutics Inc [2018-12-10] 5.3
Farallon Capital Management LLC Protagonist Therapeutics Inc [2018-08-20] 1.9
Great Point Partners LLC Protagonist Therapeutics Inc [2018-07-02] 6.95
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2018-05-24] 3.4
Pharmstandard International Sa Protagonist Therapeutics Inc [2017-02-13] 5.88
Canaan X LP Protagonist Therapeutics Inc [2017-01-26] 14.7
FMR LLC Protagonist Therapeutics Inc [2016-10-11] 0.0
Aisling Capital IV LP Protagonist Therapeutics Inc [2016-09-12] 5.1
Lilly Ventures Fund I LLC Protagonist Therapeutics Inc [2016-08-26] 12.9
RA Capital Management LLC Protagonist Therapeutics Inc [2016-08-25] 6.8
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2016-08-19] 0.69
Johnson & Johnson Protagonist Therapeutics Inc [2016-08-19] 15.0
Form 3/4/5 Filer 2011 - 2025
Protagonist Therapeutics, Inc
Patel Dinesh V Ph D
Molina Arturo MD
Selick Harold E
Ali Asif
Waddill William D.
O'Dowd Sarah A
Williams Lewis T
Giraudo Bryan
Gupta Suneel
Swisher Daniel N JR
Noonberg Sarah B.
Liu David Y
Kalkofen Donald A.
Saks Samuel R
Khosla Chaitan PhD
Shames Richard S.
Murphy Niall
O'Neil Thomas P.
Shanafelt Armen
Canaan Partners X LLC
Canaan X LP
Adage Capital Advisors, L.L.C.
Adage Capital Partners, L.P.
Adage Capital Partners GP LLC
Atchinson Robert
Gross Phillip
Grant Julie Papanek
Hodder William A
Johnson & Johnson
Johnson & Johnson Innovation - JJDC, Inc.
Lilly Ventures Fund I LLC
Torres S. Edward
Hall Steven Edward
LV Management Group, LLC
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 9,482,436 9,630,341
Farallon Capital Management LLC [2025-06-30] OTR 6,172,006 6,172,006
RTW Investments LP [2025-06-30] SOLE 5,756,277 5,756,277
Vanguard Group Inc [2025-06-30] SOLE 0 4,234,689
Deep Track Capital LP [2025-06-30] SOLE 3,245,899 3,245,899
BVF Inc/IL [2025-06-30] DFND 0 3,211,041
State Street Corp [2025-06-30] DFND 3,059,580 3,207,543
UBS Group AG [2025-06-30] DFND 2,500,942 2,501,251
Johnson & Johnson [2025-06-30] DFND 0 2,449,183
Geode Capital Management LLC [2025-06-30] DFND 1,444,230 1,444,230
Adage Capital Partners GP LLC [2025-06-30] SOLE 1,092,262 1,092,262
Commodore Capital LP [2025-06-30] SOLE 1,075,000 1,075,000
Perceptive Advisors LLC [2025-06-30] SOLE 1,074,448 1,074,448
Wellington Management Group LLP [2025-06-30] DFND 0 1,037,738
Adar1 Capital Management LLC [2025-06-30] SOLE 948,069 948,069
Woodline Partners LP [2025-06-30] SOLE 946,884 946,884
Morgan Stanley [2025-06-30] DFND 827,693 868,963
Bank of America Corp /DE/ [2025-06-30] DFND 18,448 851,832
Jefferies Financial Group Inc. [2025-06-30] DFND 824,019 824,019
American Century Companies Inc [2025-06-30] DFND 737,097 813,995
Goldman Sachs Group Inc [2025-06-30] DFND 761,681 767,068
Driehaus Capital Management LLC [2025-06-30] SOLE 586,206 757,710
Pictet Asset Management Holding SA [2025-06-30] SOLE 680,197 751,977
Lynx1 Capital Management LP [2025-06-30] OTR 0 733,014
Invesco Ltd. [2025-06-30] DFND 0 721,680
Northern Trust Corp [2025-06-30] DFND 581,230 582,998
Charles Schwab Investment Management Inc [2025-06-30] SOLE 575,320 575,364
FMR LLC [2025-06-30] DFND 534,369 538,432
Holocene Advisors LP [2025-06-30] SOLE 530,326 530,326
Janus Henderson Group PLC [2025-06-30] DFND 0 446,828
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com